awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26801507-A9DFEE42-2D53-49A9-97ED-B3F08D3229B1
Q26801507-A9DFEE42-2D53-49A9-97ED-B3F08D3229B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801507-A9DFEE42-2D53-49A9-97ED-B3F08D3229B1
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL
P2860
Q26801507-A9DFEE42-2D53-49A9-97ED-B3F08D3229B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801507-A9DFEE42-2D53-49A9-97ED-B3F08D3229B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a54be363bfa0b11fa4b595656636d3c8ceba7b5
P2860
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.